|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Patento numeris | 3287140 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16782601.5 |
| Europos patento paraiškos padavimo data | 2016-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/079571 |
| Data | 2016-04-18 |
| (87) | Numeris | WO 2016/169454 |
| Data | 2016-10-27 |
| (30) | Numeris | Data | Šalis |
| 201510189156 | 2015-04-21 | CN |
| (72) |
TAN, Jianping , CN
WANG, Bingzhang , CN
|
| (73) |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. ,
No.36 Jinghai Er Road BDA, Beijing 100176,
CN
Beijing Staidson Medical Technology Co., Ltd. , Room 501,Building 5, No.36 Jinghai Er Road, BDA, Beijing 100176, CN |
| (54) | NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION |
| NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION |